Maspin reduces prostate cancer metastasis to bone

Urologic Oncology: Seminars and Original Investigations

Volumn 26, Issue 6, 2008, Pages 652-658

  Hall, Devon C ^a   Johnson Pais, Teresa L ^a   Grubbs, Barry ^a   Bernal, Rosie ^a   Leach, Robin J ^a   Padalecki, Susan S ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Bone metastases; Chromosome 18; Maspin

Indexed keywords

MASPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL ARTIFICIAL CHROMOSOME; BONE METASTASIS; CANCER INHIBITION; CHROMOSOME 18; CONTROLLED STUDY; DISEASE SEVERITY; GENETIC TRANSFECTION; GENOME; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MICROENVIRONMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR CELL;

ANIMALS; BONE NEOPLASMS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 18; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICE; PROSTATIC NEOPLASMS; RNA, MESSENGER; SERPINS;

EID: 55249087501     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.07.017     Document Type: Article

References (24)

1. Sager R., Sheng S., Anisowicz A., et al. RNA genetics of breast cancer: Maspin as paradigm. Cold Spring Harb Symp Quant Biol 59 (1994) 537-546
2. Schaefer J.S., and Zhang M. Role of maspin in tumor metastasis and angiogenesis. Curr Mol Mod 3 (2003) 653-658
3. Sheng S., Carey J., Seftor E.A., et al. Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 93 (1996) 11669-11674
4. Maass N., Hojo T., Zhang M., et al. Maspin-a novel protease inhibitor with tumor-suppressing activity in breast cancer. Acta Oncol 39 (2000) 931-934
5. Pierson C.R., McGowen R., Grignon D., et al. Maspin in up-regulated in premalignant prostate epithelia. Prostate 53 (2002) 255-262
6. Zou Z., Anisowicz A., Hendrix M.J., et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263 (1994) 526-529
7. Shi H.Y., Liang R., Templeton N.S., et al. Inhibition of breast tumor progression by systemic delivery of the maspin gene in a syngeneic tumor model. Mol Ther 5 (2002) 755-761
8. Shi H.Y., Zhang W., Liang R., et al. Blocking tumor growth, invasion and metastasis by maspin in a syngeneic breast cancer model. Cancer Res 61 (2001) 6945-6951
9. Zhang M., Volpert O., Shi Y.H., et al. Maspin is an angiogenesis inhibitor. Nat Med 6 (2000) 196-199
10. Cher M.L., Biliran Jr. H.R., Bhagat S., et al. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci USA 100 (2003) 7847-7852
11. Wang Z., Engler P., Longacre A., et al. An efficient method of high-fidelity BAC/PAC retrofitting with a selectable marker for a mammalian cell transfection. Genome Res 11 (2001) 137-142
12. Padalecki S.S., Weldon K.S., Reveles X.T., et al. Chromosome 18 suppresses prostate cancer metastases. Urol Oncol 21 (2003) 366-373
13. Yin Z., Babaian R.J., Troncoso P., et al. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Oncogene 20 (2001) 2273-2280
14. Padalecki S.S., Troyer D.A., Hansen M.F., et al. Identification of two distinct regions of allelic imbalance on chromosome 18q in metastatic prostate cancer. Int J Cancer 85 (2000) 654-658
15. Ueda T., Komiya A., Emi M., et al. Allelic losses on 18q21 are associated with progression and metastasis in human prostate cancers. Genes Chromosomes Cancer 20 (1997) 140-147
16. Nakao K., Mehta K.R., Fridlyand J., et al. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 25 (2004) 1345-1357
17. Devilee P., van Vliet M., Kuipers-Dijkshoorn N., et al. Somatic genetic changes on chromosome 18 in breast carcinomas: Is the DCC gene involved?. Oncogene 6 (1991) 311-319
18. Chenevix-Trench G., Leary J., Kerr J., et al. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene 7 (1992) 1059-1065
19. Shiseki M., Kohno T., Nishikawa R., et al. Frequent allelic losses on chromosome 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res 54 (1994) 5643-5648
20. Hahn S.A., Schutte M., Hoque A.T., et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271 (1996) 350-353
21. Biliran Jr. H., and Sheng S. Pleiotropic inhibition of pericellular urokinase-type plasminogen activator system by endogenous tumor suppressive maspin. Cancer Res 61 (2001) 8676-8682
22. McGowen R., Billiran Jr. H., Sager R., and Sheng S. The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res 60 (2000) 4771-4778
23. Bagi C.M. Skeletal implications of prostate cancer. J Musculoskelet Neuronal Interact 3 (2003) 112-117
24. Yin S., Lockett J., Meng Y., et al. Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase type plasminogen activator receptor system. Cancer Res 66 (2006) 4173-4181